Drawing for ROTA

USPTO serial 88234756

ROTA

Reviewed by CopyMark Law Group

Reg. 5963001Status 710
Filing date
Status date
Registration date
Jan 14, 2020
Examiner
INGRAM, KYLE G
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ROTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Devon E. White

DEVON E. WHITE WYRICK ROBBINS YATES & PONTON LLP4101 Lake Boone Trail, Suite 300RALEIGH, NC 27607UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Medical and scientific research services in the areas of cancer and other diseases; Providing medical and scientific research information, consultancy, and advisory services, all in the fields of treatment of cancer; Laboratory research services relating to pharmaceuticals; Pharmaceutical research in the field of oncology; Oncology research; Research and development in the biotechnology and oncology fields; Drug testing and discovery services in the field of oncology; product safety testing; Technological research and development relating to the chemical and pharmaceutical industry in the field of oncology; Pharmaceutical product evaluation in the field of cancer treatment drugs; Research and development in the field of personalized medicine and its delivery to patients; Research and development of personalized cancer treatments; Scientific research, development, engineering, testing, and analytical services in the fields of medicine, pharmaceuticals, genetics, and oncology; Biological research, namely, biological sample characterization, screening, and analysis services for scientific research purposes; medical and scientific research in the fields of diseases and diagnosing and treating diseases; Providing medical testing services in the field of cancer research and disease classification; Laboratory testing services, namely, conducting medical tests on biological samples for scientific research purposes; Compiling data for medical and scientific research, clinical trials, and drug admissionSECTION 8 - CANCELLEDSep 16, 2019
044Medical services; Clinical and medical laboratory testing services and information for diagnostic purposes in the fields of disease diagnostics and personalized medicine; Consulting services in the field of genetic testing for medical purposes; Consulting services in the field of medical testing for diagnostic purposes; Medical analysis services of patient medical data for the treatment of cancer; Medical services in the field of oncology; Providing personalized drug therapy services for cancer patients; Growing cancer cells in tissue culture and assessing the cells for diagnostic and prognostic purposes; laboratory testing services for medical diagnostic or treatment purposesSECTION 8 - CANCELLEDSep 16, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 24, 2026C8..CANCELLED SEC. 8 (6-YR)—
Jan 14, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 14, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 13, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Dec 12, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 18, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 18, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 7, 2019IUAFUSE AMENDMENT FILED—
Nov 7, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 9, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 14, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 14, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 24, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 11, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 10, 2019ALIEASSIGNED TO LIE—
Mar 18, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Mar 18, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 18, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 18, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 15, 2019DOCKASSIGNED TO EXAMINER—
Jan 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 22, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance